1. Home
  2. TSCO vs UTHR Comparison

TSCO vs UTHR Comparison

Compare TSCO & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tractor Supply Company

TSCO

Tractor Supply Company

HOLD

Current Price

$33.91

Market Cap

19.3B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$571.39

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSCO
UTHR
Founded
1938
1996
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3B
25.1B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
TSCO
UTHR
Price
$33.91
$571.39
Analyst Decision
Buy
Buy
Analyst Count
22
14
Target Price
$53.05
$567.57
AVG Volume (30 Days)
8.8M
387.7K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
2.76%
N/A
EPS Growth
0.98
13.07
EPS
2.06
27.86
Revenue
$15,524,046,000.00
$1,483,300,000.00
Revenue This Year
$7.32
$6.39
Revenue Next Year
$6.01
$14.18
P/E Ratio
$17.08
$20.56
Revenue Growth
4.31
2.38
52 Week Low
$34.37
$272.18
52 Week High
$63.99
$607.89

Technical Indicators

Market Signals
Indicator
TSCO
UTHR
Relative Strength Index (RSI) 17.52 55.41
Support Level N/A $560.16
Resistance Level $56.04 $593.65
Average True Range (ATR) 1.35 12.17
MACD -0.69 -2.95
Stochastic Oscillator 2.11 33.53

Price Performance

Historical Comparison
TSCO
UTHR

About TSCO Tractor Supply Company

Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,395 of its namesake banners in 49 states, along with 207 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2025, revenue consisted primarily of livestock, equine & agriculture (around 30%), companion animal (25%), and seasonal & recreation (around 25%).

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: